# Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

Study · id `cardio:ct-nct03795298` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03795298](<https://clinicaltrials.gov/study/NCT03795298>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03795298

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1600 participants.

## Technical summary

Registry record NCT03795298. Randomized; no masking; primary purpose prevention. Start 2019-05-20 (actual); primary completion 2024-07-24 (actual). Results posted on 2025-09-18.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1600 participants (enrolled count; ClinicalTrials.gov record NCT03795298, source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)
- Started: 2019-05-20 (actual) (ClinicalTrials.gov record NCT03795298, source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)
- Primary completion: 2024-07-24 (actual) (ClinicalTrials.gov record NCT03795298, source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)
- Completion: 2024-07-24 (actual) (ClinicalTrials.gov record NCT03795298, source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)
- Results first posted: 2025-09-18 (ClinicalTrials.gov record NCT03795298, source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)
- Countries: United States; Australia; Belgium; Denmark; France; Germany; Italy; Netherlands; Poland; Spain (ClinicalTrials.gov record NCT03795298, source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03795298-2025-09-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
- Acronym: OPTION
- Condition: Atrial Fibrillation
- Intervention (Device): WATCHMAN FLX Implant
- Intervention (Drug): Market-approved OAC
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Left Atrial Appendage Closure after Ablation for Atrial Fibrillation (`cardio:pubmed-39555822`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk - a sub-analysis of the OPTION study (`cardio:pubmed-42225271`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5e9d405464d8d575d530623b09ff64769184d68006a856ef1023a163e5625f89
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
